Metraipolis › archive › dc_d8ae6ff760fc

The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis — Europe PMC PMID:41237182

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41237182
DOI
10.1371/journal.pone.0307128
License (as archived)
solo-consultazione
Archived
2026-11-08T13:24:56.022Z
SHA-256 of the archived text
a52e1573c781ff4c766c30de5053b18c903aec2b7adf0143fe62f9c16463ed41
Stable URL of this page
https://metraipolis.com/documento/dc_d8ae6ff760fc

How to cite

The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis — Europe PMC PMID:41237182 — Europe PMC (en), https://europepmc.org/article/MED/41237182 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8ae6ff760fc (Metraipolis archive dc_d8ae6ff760fc, sha256 a52e1573c781ff4c766c30de5053b18c903aec2b7adf0143fe62f9c16463ed41)
BibTeX
@misc{dcd8ae6ff760fc,
  title = {The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis — Europe PMC PMID:41237182},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41237182},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8ae6ff760fc; sha256 a52e1573c781ff4c766c30de5053b18c903aec2b7adf0143fe62f9c16463ed41},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41237182. Agents can read the archived copy with the MCP tool read_document.